RIBOZYME PHARMACEUTICALS, INC.
Patent Owner
Stats
- 34 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Nov 24, 2005 most recent publication
Details
- 34 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 6,210 Total Citation Count
- Sep 25, 1989 Earliest Filing
- 135 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2003/0143,708 Method and reagent for the treatment of alzheimer's diseaseDec 20, 00Jul 31, 03[A61K, C07H, C12P, C12N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6686463 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivativesAug 31, 01Feb 03, 04[C07H]
6673611 Nucleic acid molecules with novel chemical compositions capable of modulating gene expressionMay 25, 01Jan 06, 04[C07H, C12Q, C12P, C12N]
6586238 Enzymatic nucleic acids containing 5'-and or 3'-cap structuresOct 15, 99Jul 01, 03[C07H, C12N]
6509460 Nucleoside triphosphates and their incorporation into oligonucleotidesAug 23, 00Jan 21, 03[C07H]
6489465 Xylofuranosly-containing nucleoside phosphoramidites and polynucleotidesSep 21, 01Dec 03, 02[C07H, C12Q, A01N]
6469158 Synthesis, deprotection, analysis and purification of RNA and ribozymesMay 02, 95Oct 22, 02[C07H]
6395713 Compositions for the delivery of negatively charged moleculesJul 21, 98May 28, 02[A61K, A01N, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2005/0261,212 RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering RNAAbandonedJul 26, 02Nov 24, 05[A61K, C12N]
2005/0074,760 Enzymatic nucleic acids containing 5'-and/or 3'-cap structuresAbandonedMay 06, 03Apr 07, 05[C07H, A61K, C12Q, C12N]
2004/0102,389 Nucleic acid-mediated treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)AbandonedNov 04, 02May 27, 04[A61K, C12N]
2004/0033,568 Method and reagent for treatment of diseases caused by expression of the c-myc geneAbandonedDec 18, 02Feb 19, 04[C07H]
2004/0023,292 Method and reagent for the detection of proteins and peptidesAbandonedOct 18, 02Feb 05, 04[C12P, G01N, G06F]
2003/0207,837 Method and reagent for the induction of graft tolerance and reversal of immune responsesAbandonedMay 19, 03Nov 06, 03[C07H, A61K, C12N]
2003/0203,870 Method and reagent for the inhibition of NOGO and NOGO receptor genesAbandonedMay 06, 03Oct 30, 03[A61K, C07H]
2003/0191,077 Method and reagent for the treatment of asthma and allergic conditionsAbandonedAug 28, 02Oct 09, 03[A61K, C07H, C12Q, C12N]
2003/0186,909 Nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptorsAbandonedOct 21, 02Oct 02, 03[A61K, C07H]
2003/0186,923 Method and reagent for inhibiting P-glycoprotein (mdr-1 gene)AbandonedMay 15, 03Oct 02, 03[A61K, C07H, C12N]
2003/0175,950 RNA interference mediated inhibition of HIV gene expression using short interfering RNAAbandonedAug 21, 02Sep 18, 03[C07H, A61K, C12P]
2003/0170,644 Method for screening nucleic acid catalystsAbandonedMar 29, 02Sep 11, 03[C07H, C12Q, C12P]
2003/0171,311 Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infectionAbandonedMar 26, 01Sep 11, 03[A61K, C07H]
2003/0153,521 Nucleic acid treatment of diseases or conditions related to levels of RasAbandonedSep 10, 02Aug 14, 03[A61K, C12Q, C12N]
2003/0143,732 RNA interference mediated inhibition of adenosine A1 receptor (ADORA1) gene expression using short interfering RNAAbandonedAug 20, 02Jul 31, 03[C07H, C12N]
2003/0140,362 In vivo models for screening inhibitors of hepatitis B virusAbandonedOct 24, 02Jul 24, 03[C12Q, A01K, G01N]
2003/0134,806 Method and reagent for the inhibition of gridAbandonedFeb 23, 01Jul 17, 03[A61K, C07H]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
